UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4101
Simulations Plus
SLP
$371M
| $3.85M | ﹤0.01% |
138,118
+123,408
| +839% | +$3.76M |
|
4102
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$476M
| $3.84M | ﹤0.01% |
106,157
+12,523
| +13% | +$474K |
|
4103
Designer Brands
DBI
$333M
| $3.84M | ﹤0.01% |
719,233
+698,194
| +3,319% | +$3.91M |
|
4104
ADS-TEC Energy
ADSE
$889M
| $3.84M | ﹤0.01% |
247,444
+246,466
| +25,201% | +$3.42M |
|
|
TRML
4105
DELISTED
Tourmaline Bio
TRML
| $3.84M | ﹤0.01% |
189,231
+177,385
| +1,497% | +$4.47M |
|
4106
Ingevity
NGVT
$2.68B
| $3.83M | ﹤0.01% |
93,991
-4,578
| -5% | -$191K |
|
4107
Trinity Capital Inc.
TRIN
$1.71B
| $3.82M | ﹤0.01% |
264,329
+89,509
| +51% | +$1.26M |
|
4108
Alpha and Omega Semiconductor
AOSL
$1.08B
| $3.82M | ﹤0.01% |
103,209
+80,590
| +356% | +$3M |
|
4109
PUT
Alcon
ALC
$35B
| $3.82M | ﹤0.01% |
45,000
-160,900
| -78% | -$14.5M |
|
4110
Ardmore Shipping
ASC
$683M
| $3.82M | ﹤0.01% |
314,275
+205,176
| +188% | +$2.79M |
|
|
JAMF
4111
DELISTED
Jamf
JAMF
| $3.81M | ﹤0.01% |
271,054
+196,356
| +263% | +$3.1M |
|
4112
Invesco PHLX Semiconductor ETF
SOXQ
$2.76B
| $3.81M | ﹤0.01% |
97,021
+92,596
| +2,093% | +$3.72M |
|
4113
iShares Global Utilities ETF
JXI
$311M
| $3.79M | ﹤0.01% |
59,151
+40,138
| +211% | +$2.73M |
|
4114
Ginkgo Bioworks
DNA
$521M
| $3.79M | ﹤0.01% |
386,347
+369,607
| +2,208% | +$3.17M |
|
4115
CALL
Cardinal Health
CAH
$55.4B
| $3.78M | ﹤0.01% |
32,000
| – | – |
|
|
4116
PUT
Cardinal Health
CAH
$55.4B
| $3.78M | ﹤0.01% |
32,000
| – | – |
|
4117
10x Genomics
TXG
$6.61B
| $3.78M | ﹤0.01% |
263,527
+18,773
| +8% | +$296K |
|
4118
Phathom Pharmaceuticals
PHAT
$692M
| $3.78M | ﹤0.01% |
465,616
+393,675
| +547% | +$4.88M |
|
4119
Adeia
ADEA
$3.11B
| $3.76M | ﹤0.01% |
269,308
+83,898
| +45% | +$1.06M |
|
4120
La-Z-Boy
LZB
$1.69B
| $3.75M | ﹤0.01% |
86,098
+59,413
| +223% | +$2.51M |
|
4121
CALL
iQIYI
IQ
$1.28B
| $3.75M | ﹤0.01% |
1,865,800
| – | – |
|
4122
Redwire
RDW
$3.25B
| $3.74M | ﹤0.01% |
227,432
+216,785
| +2,036% | +$2.33M |
|
|
SRV
4123
NXG Cushing Midstream Energy Fund
SRV
$216M
| $3.74M | ﹤0.01% |
84,009
+77,578
| +1,206% | +$3.44M |
|
4124
Ceco Environmental
CECO
$4.14B
| $3.74M | ﹤0.01% |
123,571
+93,103
| +306% | +$2.65M |
|
|
OBE
4125
Obsidian Energy
OBE
$662M
| $3.73M | ﹤0.01% |
644,350
+481,237
| +295% | +$2.74M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.